Molsidomine

Especificaciones

25717-80-0Número CAS

247-207-4Número CE

(1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidateNombre IUPAC

C9H14N4O4Fórmula química

242.23 g/molPeso molecular

molsidomine; 25717-80-0; morsydomine; Corvaton; Motazomin; Molsidolat; Morial; Molsidomina; Molsidomin; Molsidominum; Covarsal; N-Ethoxycarbonyl-3-morpholinosydnonimine; DTXSID0045171; CAS 276; Sydnone imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)-; N-Carboxy-3-morpholinosydnone imine ethyl ester; CAS276; CAS-276; D46583G77X; NSC-757398; DTXCID8025171; Korvatone; Molsicor; Molsidain; Molsi Puren; MTW Molsidomin; Fali Cor; 5-[(ethoxycarbonyl)azanidyl]-3-(morpholin-4-yl)-1,2,3lambda5-oxadiazol-3-ylium; CHEBI:31861; Molsi AZU; Heumann, Molsidomin; Molsidomin ratiopharm; Von Ct, Molsidomin; SIN10; Corvaton mite; Corvaton ret; SIN 10; 5-((ethoxycarbonyl)azanidyl)-3-(morpholin-4-yl)-1,2,3lambda5-oxadiazol-3-ylium; RefChem:389128; C01DX12; 247-207-4; SIN-10; MLS000028573; (1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate; Sydnopharm; SMR000058990; N-(Ethoxycarbonyl)-3-(4-morpholinyl)sydnone imine; N-Carboxy-3-morpholinosydnonimine ethyl ester; NCGC00015661-02; CAS-25717-80-0; N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]carbamic acid ethyl ester; Sydnone imine, N-carboxy-3-morpholino-, ethyl ester; SIN-10;Morsydomine; Molsidominum [INN-Latin]; Molsidomina [INN-Spanish]; 1,2,3-Oxadiazolium, 5-[(ethoxycarbonyl)amino]-3-(4-morpholinyl)-, inner salt; SR-05000001464; EINECS 247-207-4; BRN 3999414; UNII-D46583G77X; Molsidomine [USAN:INN:BAN:JAN]; Prestwick_863; Molsidomine (Standard); Opera_ID_238; MOLSIDOMINE [MI]; Prestwick3_000547; Lopac-M-2901; MOLSIDOMINE [INN]; MOLSIDOMINE [JAN]; MOLSIDOMINE [USAN]; MOLSIDOMINE [MART.]; BSPBio_000593; MOLSIDOMINE [WHO-DD]; MLS001146942; MLS002153869; SPECTRUM1500673; Molsidomine (JAN/USAN/INN); BPBio1_000653; CHEMBL1256353; CHEMBL1329455; CHEMBL4059924; BDBM39912; CHEBI:92623; cid_5353788; HMS501O05; HY-B1069R; HMS1569N15; HMS1921A16; HMS2089L03; HMS2092G20; HMS2096N15; HMS2232F20; HMS2235B12; HMS3262A12; HMS3649M16; HMS3713N15; MOLSIDOMINE [EP MONOGRAPH]; HY-B1069; Tox21_110192; Tox21_500725; BDBM50248123; CCG-40069; EBC-26286; s4664; AKOS015843340; AKOS015900360; AKOS015962928; AKOS026749793; Tox21_110192_1; AC-7473; CCG-220547; CS-4625; DB09282; KS-5160; NSC 757398; SDCCGSBI-0050703.P005; NCGC00015661-01; NCGC00015661-03; NCGC00015661-04; NCGC00015661-05; NCGC00015661-06; NCGC00015661-07; NCGC00015661-08; NCGC00015661-09; NCGC00015661-10; NCGC00015661-12; NCGC00015661-16; NCGC00024136-03; NCGC00024136-04; NCGC00024136-05; NCGC00024136-06; NCGC00024136-07; NCGC00261410-01; SMR001233224; SBI-0050703.P004; AB00513859; EU-0100725; ST51015046; D01320; AB00052152_14; AB00513859-02; EN300-33061232; SR-05000001464-1; SR-05000001464-3; ethoxy-N-(3-morpholin-4-yl(1,2,3-oxadiazol-5-yl))carboxamide; (1E)-1-ethoxy-N-(3-morpholinooxadiazol-3-ium-5-yl)formimidate; 1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate; (1E)-1-ethoxy-N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]methanimidate; N-(Ethoxycarbonyl)-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium-5-aminide; (1E)-1-ethoxy-N-(3-morpholin-4-yl-1,2,3-oxadiazol-3-ium-5-yl)methanimidateSinónimos